Has Seyed Mohammad Khalafi, MD received payments from drug or device companies?

Yes. Drug and device makers reported $66,051 in general payments to Seyed Mohammad Khalafi, MD across 619 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Seyed Mohammad Khalafi, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Seyed Mohammad Khalafi, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Seyed Mohammad Khalafi, MD

Thoracic Surgery (Cardiothoracic Vascular Surgery) · Fort Worth, TXNPI 1265457071

Payments from drug & device makers

$66,051in general payments, 2019–2025

Across 619 payments — averaging $106.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

CMF Medicon Surgical Inc.$19K
Getinge USA Sales, LLC$18K
Abbott$7K
Edwards Lifesciences$4K
Atricure, Inc.$4K
Boston Scientific$3K
plus $11K from 15 others

$56in research payments, 2019–2025

Across 1 payment — averaging $55.74 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Abiomed$56

What the payments were for

Royalty or licence$19,23029%
Consulting fees$6,75010%
Speaking & faculty fees$5,0358%
Travel & lodging$5,8279%
Food & beverage$29,20944%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
CMF Medicon Surgical Inc.	2	$19,230
Getinge USA Sales, LLC	293	$17,503
Abbott	67	$7,271
Edwards Lifesciences	43	$4,212
Atricure, Inc.	24	$3,576
Boston Scientific	26	$2,976
Baxter Healthcare	59	$2,201
Maquet Cardiovascular L.L.C.	16	$1,998
Abiomed	23	$1,751
Artivion, Inc.	23	$1,270
Stryker	3	$1,136
Medtronic(2 entities)	8	$658
Pylant Medical	10	$625
Johnson & Johnson(3 entities)	10	$438
Shockwave Medical, Inc	2	$355
Biotronik Inc.	3	$345
Penumbra, Inc.	2	$274
Cardiovascular Systems Inc.	2	$71
Bolton Medical Inc	1	$71
Biosense Webster, Inc.	1	$66
Arthrex	1	$24

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Acrobat-I Stabilizer$5,967
Trifecta GT Tissue Heart Valve$4,572
SYNERGY ABLATION SYSTEM$2,370
Vasoview Hemopro 2$1,629
ATRICLIP LAA EXCLUSION SYSTEM$1,509
VASOVIEW$1,500
Impella$1,240
DISSECTOR$1,129
SPY-PHI SYSTEM$1,082
HeartString III Proximal Seal$762
Acrobat$725
SAPIEN 3 Ultra RESILIA$630
ON-X AORTIC HEART VALVE WITH CONFORM-X SEWING RING AND EXTENDED HOLDER$537
OptiCross 6$492
Bioprosthetic Mitral Valve$486
AVVIGO Guidance System$406
COMET$393
Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$355
SYNERGY$352
MITRIS RESILIA Mitral Valve$315

How this compares

$66,051 in reported general payments places this provider in the 80th percentile of 424 thoracic surgery (cardiothoracic vascular surgery) providers in Texas.

See all thoracic surgery (cardiothoracic vascular surgery) providers in Texas →

Medicare billing

Part B allowed, 2024

$215,343

Medicare patients

158

Services billed

458

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	36	$573
Potassium Chloride	31	$256
ClopidogrelClopidogrel Bisulfate	36	$223
Bupropion XlBupropion Hcl	12	$197
Metoprolol Succinate	13	$196
Carvedilol	19	$101
Atorvastatin Calcium	20	$100
Metoprolol Tartrate	27	$77
Furosemide	20	$69
Tramadol Hcl	18	$67

Paid to pharmacies, not to this prescriber.

Other thoracic surgery (cardiothoracic vascular surgery) in Fort Worth

Robert SmithPlano$2.9M
Michael ReardonHouston$2.7M
William RyanPlano$2.1M
Faraz KerendiAustin$1.6M
Robert HebelerDallas$1.2M
William BrinkmanPlano$1.2M
Robert RipleyHouston$817K
Michael MackPlano$796K
Katherine HarringtonPlano$723K
Danny RamzyHouston$620K

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →